Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Net Cash Flow (2018 - 2026)

Zai Lab (ZLAB) posted Net Cash Flow of -$28.6 million for Q1 2026, up 24.16% sequentially from -$37.7 million in Q4 2025, and down 109.31% YoY from $307.6 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Net Cash Flow (2018 - 2026) Analysis & Trends

Zai Lab has reported Net Cash Flow for 9 years, with the latest figure at -$28.6 million in Q1 2026.

  • Quarterly Net Cash Flow fell 109.31% year-over-year to -$28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$106.8 million (down 200.1% YoY) and the FY2025 annual result came in at $229.4 million, up 195.53% from the prior year.
  • Net Cash Flow grew to -$28.6 million in Q1 2026 per ZLAB's latest filing, from -$37.7 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $442.6 million in Q3 2022 and troughed at -$165.7 million in Q4 2024.
  • A 5-year average of -$12.0 million and a median of -$28.6 million in 2026 frame the typical range for Net Cash Flow.
  • The sharpest annual moves came in 2024 and 2025: Net Cash Flow tumbled 247229.85% in 2024, then soared 883.31% in 2025.
  • Over 5 years, Net Cash Flow stood at -$113.9 million in 2022, then surged by 99.94% to -$67000.0 in 2023, then sank by 247229.85% to -$165.7 million in 2024, then jumped by 77.22% to -$37.7 million in 2025, then advanced by 24.16% to -$28.6 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$28.6 million, -$37.7 million, and -$15.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn -46.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.12 Mn
Mar 31, 2026 -28.63 Mn
Dec 31, 2025 -37.75 Mn
Sep 30, 2025 -15.30 Mn
Jun 30, 2025 -25.10 Mn
Mar 31, 2025 307.58 Mn
Dec 31, 2024 -165.71 Mn
Sep 30, 2024 -14.50 Mn
Jun 30, 2024 -20.70 Mn
Mar 31, 2024 -39.27 Mn
Dec 31, 2023 -67,000.00
Sep 30, 2023 -70.70 Mn
Jun 30, 2023 -17.49 Mn
Mar 31, 2023 -127.13 Mn
Dec 31, 2022 -113.86 Mn
Sep 30, 2022 442.64 Mn
Jun 30, 2022 -161.12 Mn
Mar 31, 2022 -117.01 Mn
Dec 31, 2021 -434.76 Mn
Sep 30, 2021 -367.74 Mn